Richard Milne responds to PHARMAC on discounting future health benefits and costs.
Milne
Richard
R
D017281:Cost of Illness; D003362:Cost-Benefit Analysis; D004345:Drug Industry; D005544:Forecasting; D017048:Health Care Costs / Q000639:trends*; D006801:Humans; D009313:National Health Programs / Q000191:economics* / Q000639:trends*; D009520:New Zealand; D011314:Preventive Health Services / Q000191:economics